IP special: Allergan may use Native American sovereign immunity to shield itself from patent challenges
To prevent attempts from generics companies to invalidate the patent, pharmaceutical company Allergan has assigned the Restasis IP rights to the St Regis Mohawk tribe.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>